PTK2 and breast cancer: In translational studies by Borges, Jordan and colleagues, EVs from young women with breast cancer compared to healthy donors conferred invasive outcomes on tumor cells through focal adhesion kinase (FAK) signaling, demonstrating the use of proteomics to identify novel candidates for conditioning metastatic potential in this patient population (Jordan et al., 2020).